Vote: Floor vote
NY SenateJun 2, 2026Result: passedSenate vote on A3283, the matching Assembly bill.
Senate bill · S9279 (2025-26)
New York State Senate
Same as A3283, the matching bill in the Assembly.
Passed as A3283, the matching Assembly bill.
Requires gene synthesis providers and manufacturers of gene synthesis equipment to operate in accordance with rules and regulations issued by the department of health, including identifying potentially dangerous sequences and maintaining certain records.
Summary from NY Open Legislation. How we handle summaries
Amends the Public Health Law.
From NY Open Legislation, the NY Senate and Assembly, and official rosters. This record was last updated Oct 23, 2026. About our data
Following needs an Agora account. You will sign in first, then come back to this page.
Choose the position closest to yours. You'll sign in or create an account to save it.
"To amend the public health law, in relation to the operation of gene synthesis providers and manufacturers of gene synthesis equipment"
Filed with the bill. Read it on nysenate.gov (opens in a new tab)
Passed the legislature and is awaiting a signature.
Health · New York State Assembly
Also referred to Health · New York State Senate.
The sponsor's argument
Gene synthesis describes the synthetic biology process utilized to create artificial genes. This is most commonly done within a laboratory setting, and recently, has been used widespread by large biotech corpo- rations. Recent advancements in gene synthesis technology present both great opportunities as well as great risks. New York currently lacks even basic regulations to ensure gene synthesis technologies do not put bioweapons in the hands of terrorists. For example, as the law currently stands, gene synthesis producers do not even need to screen orders against federal databases of dangerous individuals who pose a known threat to the state. By requiring gene synthesis providers and manufac- turers of gene synthesis equipment to act in accordance with Department of Health regulations, developed in consideration of the International Gene Synthesis Consortium protocols, this bill will address the poten- tial catastrophic threat posed by New York's lack of gene synthesis safety controls.
This is the sponsor's own case for the bill, quoted from their memorandum. It is not Agora's description of what the bill does.
NY SenateJun 2, 2026Result: passedSenate vote on A3283, the matching Assembly bill.
Senate HealthMay 19, 2026Result: passed
3RD Reading CAL.1239
3RD READING CAL.1239
NY Senate
Passed a chamber
PASSED SENATE
NY Senate
Substituted
SUBSTITUTED FOR S9279A
NY Senate
Advanced to Third Reading
ADVANCED TO THIRD READING
NY Senate
2ND Report CAL.
2ND REPORT CAL.
NY Senate
1ST Report CAL.1239
1ST REPORT CAL.1239
NY Senate
Sent to the executive
DELIVERED TO SENATE
NY Assembly
Passed a chamber
PASSED ASSEMBLY
NY Assembly
Referred to committee
REFERRED TO HEALTH
NY Senate
Advanced to Third Reading CAL.315
ADVANCED TO THIRD READING CAL.315
NY Assembly
Reported out of committee
REPORTED
NY Assembly
Amend and Recommit to Health
AMEND AND RECOMMIT TO HEALTH
NY Senate
Amend and Recommit to Health
AMEND AND RECOMMIT TO HEALTH
NY Assembly
Referred to committee
REFERRED TO HEALTH
NY Senate
Amend and Recommit to Health
AMEND AND RECOMMIT TO HEALTH
NY Assembly
Referred to committee
REFERRED TO HEALTH
NY Assembly
Amend (t) and Recommit to Health
AMEND (T) AND RECOMMIT TO HEALTH
NY Assembly
Referred to committee
REFERRED TO HEALTH
NY Assembly